UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples

BMC medical genetics, 2008-05, Vol.9 (1), p.39-39, Article 39

2008

Volltextzugriff (PDF)

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

Human brain mapping, 2004-07, Vol.22 (3), p.246-260

2004

Volltextzugriff (PDF)

Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults

Psychiatry research. Neuroimaging, 2010-05, Vol.182 (2), p.123-133

2010

Volltextzugriff (PDF)

Brain-derived neurotrophic factor gene ( BDNF) variants and schizophrenia: An association study

Progress in neuro-psychopharmacology & biological psychiatry, 2006-07, Vol.30 (5), p.924-933

2006

Volltextzugriff (PDF)

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain

Synapse (New York, N.Y.), 2004-08, Vol.53 (2), p.57-67

2004

Volltextzugriff (PDF)

Altered White Matter Gray Matter Proportions in the Striatum of Patients With Schizophrenia: A Volumetric MRI Study

The American journal of psychiatry, 2005-12, Vol.162 (12), p.2315-2321

2005

Volltextzugriff (PDF)

DAP12 Signaling Regulates Plasmacytoid Dendritic Cell Homeostasis and Down-Modulates Their Function during Viral Infection

Journal of Immunology, 2006-09, Vol.177 (5), p.2908-2916

2006

Volltextzugriff (PDF)

Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression

BMC psychiatry, 2006-08, Vol.6 (1), p.31-31, Article 31

2006

Volltextzugriff (PDF)

CARD6 Is Interferon Inducible but Not Involved in Nucleotide-Binding Oligomerization Domain Protein Signaling Leading to NF-κB Activation

Molecular and Cellular Biology, 2008-03, Vol.28 (5), p.1541-1552

2008

Volltextzugriff (PDF)

DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study

Neuropsychobiology, 2009-01, Vol.59 (3), p.142-150

2009

Volltextzugriff (PDF)

Autoradiographic mapping of dopamine-D sub(2)-D sub(3) receptor stimulated [ super(35)S]GTP gamma S binding in the human brain

The European journal of neuroscience, 2005-07, Vol.22 (1), p.65-71

2005

Volltextzugriff (PDF)

Dystrobrevin-binding protein 1 gene ( DTNBP1 ) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers

European neuropsychopharmacology, 2011-09, Vol.21 (9), p.700-704

2011

Volltextzugriff (PDF)

Characterization of Patients with Schizophrenia and Related Psychoses: Evaluation of Different Diagnostic Procedures

Psychopathology, 2006-01, Vol.39 (6), p.286-295

2006

Volltextzugriff (PDF)

Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers

Journal of Neural Transmission, 2008-12, Vol.115 (12), p.1695-1699

2008

Volltextzugriff (PDF)

In vitro imaging techniques in neurodegenerative diseases

Molecular imaging and biology, 2007-07, Vol.9 (4), p.161-175

2007

Volltextzugriff (PDF)

Neuroimaging of mirtazapine enantiomers in humans

Psychopharmacologia, 2008-10, Vol.200 (2), p.273-279

2008

Volltextzugriff (PDF)

Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study

Journal of medicinal chemistry, 1990-08, Vol.33 (8), p.2305-2309

1990

Volltextzugriff (PDF)

TCR repertoire dynamics in the pancreatic lymph nodes of non-obese diabetic (NOD) mice at the time of disease initiation

Molecular immunology, 2008-06, Vol.45 (11), p.3059-3064

2008

Volltextzugriff (PDF)

Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides

Journal of medicinal chemistry, 1986-01, Vol.29 (1), p.61-69

1986

Volltextzugriff (PDF)

Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides

Journal of medicinal chemistry, 1985-09, Vol.28 (9), p.1263-1269

1985

Volltextzugriff (PDF)

Potential antipsychotic agents. 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds

Journal of medicinal chemistry, 1990-04, Vol.33 (4), p.1155-1163

1990

Volltextzugriff (PDF)

Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.948-955

1991

Volltextzugriff (PDF)

Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET

Science (American Association for the Advancement of Science), 1986-01, Vol.231 (4735), p.258-261

1986

Volltextzugriff (PDF)

DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (3), p.1317-1325

2007

Volltextzugriff (PDF)

The Effects of Breeder Loss on Wolves

The Journal of wildlife management, 2008-01, Vol.72 (1), p.89-98

2008

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults

Brain-derived neurotrophic factor gene ( BDNF) variants and schizophrenia: An association study

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain

Altered White Matter Gray Matter Proportions in the Striatum of Patients With Schizophrenia: A Volumetric MRI Study

DAP12 Signaling Regulates Plasmacytoid Dendritic Cell Homeostasis and Down-Modulates Their Function during Viral Infection

Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression

CARD6 Is Interferon Inducible but Not Involved in Nucleotide-Binding Oligomerization Domain Protein Signaling Leading to NF-κB Activation

DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study

Autoradiographic mapping of dopamine-D sub(2)-D sub(3) receptor stimulated [ super(35)S]GTP gamma S binding in the human brain

Dystrobrevin-binding protein 1 gene ( DTNBP1 ) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers

Characterization of Patients with Schizophrenia and Related Psychoses: Evaluation of Different Diagnostic Procedures

Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers

In vitro imaging techniques in neurodegenerative diseases

Neuroimaging of mirtazapine enantiomers in humans

Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study

TCR repertoire dynamics in the pancreatic lymph nodes of non-obese diabetic (NOD) mice at the time of disease initiation

Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides

Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides

Potential antipsychotic agents. 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds

Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners

Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET

DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells

The Effects of Breeder Loss on Wolves

Suchergebnisse filtern